HDACs in multiple myeloma: potential benefits in maintenance phase
Is the CR of MM patients a good objective for treatment?
The importance of individually customized treatment for CLL patients
Why has the biobank project been a success and what is the future for it?
Regis Peffault de Latour
Progress in acute myeloid leukemia treatment – collaborating to develop targeted therapies